These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15356067)

  • 21. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
    Mancini F; Cianciosi A; Reggiani GM; Facchinetti F; Battaglia C; de Aloysio D
    Fertil Steril; 2009 Jun; 91(6):2537-44. PubMed ID: 18462732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
    Kahal H; Aburima A; Ungvari T; Rigby AS; Dawson AJ; Coady AM; Vince RV; Ajjan RA; Kilpatrick ES; Naseem KM; Atkin SL
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):252-8. PubMed ID: 23278130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of laparoscopic ovarian drilling on flow mediated dilation in women with PCOS: relationship with insulin resistance and IGF-I.
    Shokeir T; El-Kannishy G
    Minerva Ginecol; 2014 Apr; 66(2):209-18. PubMed ID: 24848079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
    Erdoğan M; Karadeniz M; Alper GE; Tamsel S; Uluer H; Cağlayan O; Saygili F; Yilmaz C
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):143-7. PubMed ID: 18350479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
    Usselman CW; Yarovinsky TO; Steele FE; Leone CA; Taylor HS; Bender JR; Stachenfeld NS
    J Physiol; 2019 Jun; 597(11):2853-2865. PubMed ID: 30847930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction.
    Pepene CE
    Gynecol Endocrinol; 2012 May; 28(5):370-4. PubMed ID: 22456311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
    Soyman Z; Noyan V; Tulmac M; Yucel A; Sagsoz N; Bayrak T; Bayrak A; Cakir E
    Fertil Steril; 2011 Mar; 95(3):1067-72. PubMed ID: 21193188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
    Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
    Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
    Kaya C; Pabuccu R; Berker B; Satiroglu H
    Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular dysfunction and metabolic parameters in polycystic ovary syndrome.
    Meyer C; McGrath BP; Cameron J; Kotsopoulos D; Teede HJ
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4630-5. PubMed ID: 15870132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of carotid wall thickness and vertebro-basilar system insufficiency in patients with obese polycystic ovary syndrome.
    Coksuer H; Koplay M; Oghan F; Haliloglu B; Keskin N
    J Obstet Gynaecol Res; 2011 Aug; 37(8):997-1003. PubMed ID: 21463430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
    Alexandraki K; Protogerou AD; Papaioannou TG; Piperi C; Mastorakos G; Lekakis J; Panidis D; Diamanti-Kandarakis E
    Hormones (Athens); 2006; 5(2):126-36. PubMed ID: 16807225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.